P

PTC Therapeutics
D

PTCT

45.100
USD
-0.15
(-0.33%)
Market Closed
Volume
32,269
EPS
3
Div Yield
-
P/E
-8
Market Cap
3,478,343,949
Related Instruments
    A
    ABUS
    0.02000
    (0.63%)
    3.22000 USD
    A
    ARCT
    0.260
    (1.58%)
    16.680 USD
    A
    ARWR
    -0.050
    (-0.25%)
    19.710 USD
    C
    CRNX
    -0.120
    (-0.31%)
    38.700 USD
    C
    CRSP
    2.740
    (6.61%)
    44.200 USD
    G
    GLPG
    0.075
    (0.31%)
    23.920 USD
    R
    RARE
    1.650
    (4.00%)
    42.950 USD
    S
    SLDB
    -0.13000
    (-3.99%)
    3.13000 USD
    S
    SRPT
    -0.920
    (-0.79%)
    116.020 USD
    V
    VKTX
    1.170
    (3.56%)
    34.060 USD
    V
    VYGR
    0.22000
    (4.21%)
    5.45000 USD
    More
News

Title: PTC Therapeutics

Sector: Healthcare
Industry: Biotechnology
PTC Therapeutics Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of orally administered, small-molecule therapeutics. Its target area is RNA biology post-transcriptional control processes of the events occurring in a cell when an RNA messenger is copied from DNA during the transcription process. The discovered products address multiple therapeutic areas, including rare disorders, such as nonsense mutations in Duchenne muscular dystrophy and oncology.
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.